Pharmaceuticals: Ophthalmic Ointments Quiz
26 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following drugs are mentioned as being unstable in the listed vehicle?

  • Scopolamine (correct)
  • Homatropine (correct)
  • Pilocarpine (correct)
  • Eucatropine (correct)
  • What is the primary reason for using a base with a softening point close to body temperature in ophthalmic ointments?

  • To facilitate drug release (correct)
  • To prevent irritation to the eye (correct)
  • To enhance drug penetration
  • To ensure ease of application
  • Which of the following is a key component of the base used in both medicated and non-medicated ophthalmic ointments?

  • White petrolatum (correct)
  • Stearic acid
  • Glycerin
  • Lanolin
  • What is the primary purpose of using liquid petrolatum in ophthalmic ointments?

    <p>To improve the spreadability of the ointment (D)</p> Signup and view all the answers

    What is the main characteristic of the base in ophthalmic ointments that makes it suitable for drug release?

    <p>Softening point close to body temperature (C)</p> Signup and view all the answers

    Which of the following statements regarding the base of ophthalmic ointments is TRUE?

    <p>The base can be formulated to both medicate and prevent infections. (C)</p> Signup and view all the answers

    Which of the following approaches is NOT directly related to enhancing corneal penetration of drugs using prodrugs?

    <p>Blocking of drug metabolism in liver (A)</p> Signup and view all the answers

    What is the primary rationale behind enhancing aqueous solubility of a prodrug for improving corneal penetration?

    <p>Enhanced diffusion through the corneal epithelium (B)</p> Signup and view all the answers

    How does optimization of lipophilicity contribute to enhanced corneal penetration of prodrugs?

    <p>Improved diffusion through the corneal lipid layers (D)</p> Signup and view all the answers

    What is the primary aim of utilizing prodrugs that evade efflux pumps in corneal penetration?

    <p>To prolong drug residence time in the cornea (B)</p> Signup and view all the answers

    What is a major concern regarding ocular infections?

    <p>They can lead to vision loss. (B)</p> Signup and view all the answers

    What is the main concern regarding the use of preservatives in products intended for intraocular administration?

    <p>They can lead to irritation. (B)</p> Signup and view all the answers

    What is the critical aspect of eye-cups, droppers, and dispensers used for ocular medications?

    <p>They must be sterilized and packaged for each use. (A)</p> Signup and view all the answers

    What is the key benefit of utilizing prodrugs with improved affinity to corneal uptake transporters for enhancing penetration?

    <p>Improved drug targeting to specific corneal cells (C)</p> Signup and view all the answers

    Why are eye-cups, droppers, and dispensers crucial to preventing ocular infections?

    <p>They prevent accidental contamination of the medication. (A)</p> Signup and view all the answers

    Which preservative is the most widely used?

    <p>Benzalkonium chloride (D)</p> Signup and view all the answers

    What is the main implication of the statement "Ocular infections are extremely dangerous and can rapidly lead to the loss of vision"?

    <p>Ocular infections require prompt medical attention. (A)</p> Signup and view all the answers

    Why should preservatives be avoided in products for intraocular administration?

    <p>They can damage the cornea. (B)</p> Signup and view all the answers

    What does the regulation of eye-cup and dropper packaging aim to achieve?

    <p>Prevent contamination and ensure sterility. (C)</p> Signup and view all the answers

    What is the primary reason for using preservatives in ophthalmic products?

    <p>To reduce the risk of microbial contamination. (A)</p> Signup and view all the answers

    Which of the following is NOT a common preservative used in ophthalmic products?

    <p>Glycerin (B)</p> Signup and view all the answers

    What was the primary effect of increasing the viscosity of the pilocarpine solution?

    <p>Reduced drug drainage from the eye (C)</p> Signup and view all the answers

    How much did the concentration of pilocarpine in the aqueous humor increase after increasing viscosity?

    <p>2 times (B)</p> Signup and view all the answers

    What substance was used to increase the solution viscosity?

    <p>Methyl cellulose (B)</p> Signup and view all the answers

    What is the primary function of pilocarpine?

    <p>To reduce intraocular pressure (D)</p> Signup and view all the answers

    What is the relationship between viscosity and drug drainage?

    <p>Increasing viscosity decreases drug drainage (D)</p> Signup and view all the answers

    Study Notes

    Ocular Drug Delivery

    • Ocular drug delivery is a critical area of modern eye care, with significant opportunities and challenges.
    • The front of the eye is accessible, allowing for simple topical treatments (eye drops).
    • The back of the eye requires more advanced treatment methods, including intraocular injections and implants to allow sustained drug release (up to 2 years).
    • Emerging therapies target cells, genes, and proteins, in addition to small molecules.

    Classification of Ocular Drug Delivery Systems

    • Liquid: Solutions, suspensions, and sol-to-gel systems (Powders for reconstitution)
    • Semisolid: Ointments and gels
    • Solid: Ocular inserts

    Ideal Ophthalmic Delivery System Requirements

    • Prolong contact time with corneal tissue
    • Simple and comfortable administration for the patient
    • Non-irritating formulation
    • Appropriate rheological properties
    • Good corneal penetration

    Common Ophthalmic Dosage Forms

    • Solutions, suspensions, ointments
    • These forms are rapidly drained from the eye due to tear flow and lacrimal drainage.

    Anatomy and Physiology of the Eye

    • Diagram of the eye with labeled parts (Sclera, Iris, Cornea, Pupil, Lens, Conjunctiva, Vitreous, Choroid, Optic Nerve, Macula, Retina).

    Ocular Drug Delivery Routes and Elimination Pathways

    • Route 1: Cornea - The primary route for topically administered drugs entering the aqueous humor.
    • Route 2: Blood Retinal Barrier - Limits systemic drug entry into the posterior segment of the eye.
    • Route 3: Intravitreal Delivery - Direct access to the back of the eye.
    • Elimination 1: Aqueous humor - Drains into the systemic circulation via uveoscleral pathways.
    • Elimination 2: Trabecular Meshwork and Schlemm's Canal - Outflow route for aqueous humor.
    • Elimination 3: Vitreous Humor - Drug elimination via diffusion into the anterior chamber.
    • Elimination 4: Blood Retinal Barrier - Drug elimination via diffusion across the blood retinal barrier.

    Common Ocular Conditions and Interventions.

    • Dry Eye Syndrome: Tear volume insufficiency or poor tear quality leads to ocular surface disease. Management includes control of symptoms and protection of the ocular surface with tear substitutes and mucolytic drops. Severe cases may require anti-inflammatory drops and surgical interventions to reduce punctal drainage.
    • Cataracts: Cloudiness of the lens often related to age. Surgical replacement of the lens (with a synthetic intraocular lens) is the standard treatment.
    • Glaucoma: Optic nerve damage resulting in visual field loss; characterized by elevated intraocular pressure (IOP). Medical interventions and surgical procedures can reduce IOP to halt progression.
    • Age-Related Macular Degeneration (AMD): A degenerative disorder affecting the macula, leading to loss of central vision.
    • **Endophthalmitis:**Inflammation of the internal eye layers frequently resulting from procedures such as surgery and trauma.

    Topical Ophthalmic Preparations

    • Basal tears: A continuous secretion with an average rate of 1.2 µL/minute and reflects stimulus (irritants) with variability up to 400 µL/minute
    • Blinking: Moves tear fluids & foreign materials, to the nasal corner of the eyelid.
    • Tears contain lysozymes and immunoglobulins that help fight infections.
    • Eye drops are cleared rapidly (4-23 minutes).

    Formulating Ophthalmic Preparations

    • Osmolality: Healthy eyes have an average osmolality of 302 mmol/kg. Dry eyes often show higher tear film hyperosmolality, which contributes to disease symptoms. Hypotonic solutions increase corneal permeability and induce edema; hypertonic solutions dehydrate corneal epithelium and are irritating.
    • pH: Tear pH is near neutral (6.9-7.5), regulated by substances like carbon dioxide, bicarbonate, and proteins. Diluting solutions administered into the eye through reflex tears, is a common response. Recovery to original pH typically takes a few minutes to 20 minutes.
    • Buffering: Solutions are adjusted and buffered to ensure proper comfort (in range of physiological pH), stability, and bioavailability to enhance preservative efficacy, and aqueous drug solubility.

    Topical, Semisolid Ophthalmic Preparations

    • Ointments: Ophthalmic ointments provide extended residence time, enhancing drug absorption, and are used for drugs with poor aqueous solubility.
    • Gels: More favorable than ointments for water-soluble drugs. Different polymers like PVA, poloxamers, HPMC, and carbopols are used.
    • Mucoadhesive Systems: Increase contact time via special polymers that bind to mucin in the ocular surface.

    Intraocular Implants

    • Non-biodegradable: Reservoir-type (coated with semi-permeable polymers) or monolithic (homogeneous mix of drug and polymer) devices. Drug delivery is constant. Usually necessitates surgery for placement/removal.
    • Biodegradable: Metabolized by the body, eliminating the need for surgery (e.g., Ozurdex). Suitable for sustained drug release.
    • Examples: Vitrasert and Ozurdex as specific biodegradable systems

    Sterility of Ophthalmic Preparations

    • Sterility of ophthalmic preparations is essential as infections can cause major vision loss.
    • Terminal sterilization, filtration or preservatives control/minimize contamination.

    Surface Tension

    • Healthy tear fluid surface tension ranges from 43.6 to 46.6 mN/m
    • Solutions with lower surface tension can potentially disrupt the tear film.
    • Surfactants can help solubilize or disperse drugs.

    Viscosity

    • Viscosity-enhancing polymers are used to prolong drug retention in the precorneal tear film.
    • Increased tear film thickness due to the viscosity enhancing polymers can help stabilize the aqueous layer.

    Topical Liquid Ophthalmic Preparations

    • Solutions: Fast-acting; easily administered. Must be isotonic and homogenously formulated.
    • Suspensions: Designed to increase dwell time within the eye. Particle size and shape are carefully selected due to irritation potential.

    Submicron Emulsions and Prodrugs

    • Submicron emulsions: Enhance the absorption of poorly water-soluble drugs to improve contact time and drug release.
    • Prodrugs: Enhance corneal penetration by improving drug's lipophilicity or by changing drug's structure.

    Ocular Inserts

    • Insoluble inserts are multi-layered structures containing drugs and polymer membranes.
    • Release rate of the drug within the body is controlled by various factors (polymer composition and membrane thickness).

    Additional Considerations

    • Barriers to Ocular Drug Absorption: Tears, surface area of the cornea, and cornea anatomy are key barriers.
    • Specific Preparations: Ointments, gels, submicron emulsions, and drugs are important for ocular use.
    • Critical Factors: pH, osmolality, viscosity, and preservative use are vital to consider in preparation development.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Test your knowledge on the formulation and characteristics of ophthalmic ointments. This quiz covers key components, drug stability, and the role of prodrugs in enhancing corneal penetration. Perfect for pharmacy students and professionals looking to refresh their understanding of ocular drug delivery systems.

    More Like This

    Non-Medicated Ophthalmic Ointments
    152 questions
    Ophthalmic Drugs Flashcards
    18 questions
    Ophthalmic Procedures and Treatments Quiz
    36 questions
    Use Quizgecko on...
    Browser
    Browser